Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Oncofertility w praktyce klin.
  • Obniżka
Hypertension: A Companion to Braunwald's Heart Disease

Hypertension: A Companion to Braunwald's Heart Disease

9780323429733
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 30 DAYS
403,15 zł
342,68 zł Zniżka 60,47 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 342,68 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

The third edition of Hypertension:: A Companion to Braunwalds Heart Disease, by Drs. George L. Bakris and Matthew Sorrentino, focuses on every aspect of managing and treating patients who suffer from hypertensive disorders. Designed for cardiologists, endocrinologists and nephrologists alike, this expansive, in-depth review boasts expert guidance from contributors worldwide, keeping you abreast of the latest developments from basic science to clinical trials and guidelines. Hypertension also includes an Expert Consult digital version updated with late-breaking clinical trials, reviews of important new articles, and the latest guidance on clinical practice, all selected and masterfully edited by Dr. Eugene Braunwald.

Szczegóły produktu
Elsevier
59015
9780323429733
9780323429733

Opis

Rok wydania
2017
Numer wydania
3
Oprawa
twarda
Liczba stron
520
Wymiary (mm)
222 x 281
Waga (g)
1520

  • SECTION I: EPIDEMIOLOGY

    1. General Population and Global Cardiovascular Risk Prediction

    2. Hypertension in Latin/Hispanic Population

    3. Hypertension in East Asians and Native Hawaiians

    4. Hypertension in South Asians

    SECTION II: PATHOPHYSIOLOGY

    5. Pathogenesis of Hypertension

    6. Genetics of Hypertension

    7. Inflammation and Immunity in Hypertension

    SECTION III: DIAGNOSIS AND EVALUATION

    8. The Environment and High Blood Pressure

    9. Office Blood Pressure Measurement

    10. Home Monitoring of Blood Pressure

    11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management

    12. White Coat and Masked Hypertension

    13. Renovascular Hypertension and Ischemic Nephropathy

    14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States

    15. Secondary Hypertension: Pheochromocytoma and Paraganglioma

    16. Secondary Hypertension: Sleep Disturbances including Sleep Apnea

    17. Hypertension in Children: Diagnosis and Treatment

    SECTION IV: RISK STRATIFICATION

    18. Natural History of Untreated Hypertension

    19. Isolated Systolic Hypertension

    20. Assessment of Target Organ Damage

    SECTION V: ANTIHYPERTENSIVE THERAPY

    21. Diet and Blood Pressure

    22. Diuretics in Hypertension

    23. Alpha Blockers and Hypertension

    24. Renin Angiotensin Aldosterone System Blockers

    25. Calcium Channel Blockers

    26. Central Sympathetic Agents and Direct Vasodilators

    27. Use of Combination Therapies

    28. Devices Therapies

    29. Alternative Approaches for Lowering Blood Pressure

    SECTION VI: HYPERTENSION MANAGEMENT

    30. Approach to Difficult to Manage Primary Hypertension

    31. Hypertension in Ischemic Heart Disease

    32. Heart Failure

    33. Hypertension and Chronic Kidney Disease

    34. Transplant Hypertension

    35. Obesity

    36. Cerebrovascular Disease

    37. Diabetes Mellitus

    38. Dyslipidemia

    SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS

    39. Hypertension in Pregnancy

    40. Hypertension in Older People

    41. Hypertension in African Americans

    42. Baroreceptor Dysfunction/Orthostatic Hypotension

    43. Resistant Hypertension

    44. Hypertension and the Perioperative Period

    45. Aorta and Peripheral Arterial Disease in Hypertension

    46. Hypertensive Emergencies and Urgencies

    SECTION VIII: OUTCOME TRIALS

    47. Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists Collaboration

    SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE

    48. Team-Based Care for Hypertension Management

    49. Understanding and Improving Medication Adherence

    SECTION X: GUIDELINES

    50. Updated AHA/ACC; ESH/ISH

    51. Putting All Guidelines into Perspective

Komentarze (0)

  • Często kupowane razem

    Brak dostępnych produktów